Health-tech readers: a news brief on a partnership bringing quantitative neuroimaging into clinical workflows. It teases implications for patient care.
Key Takeaways
- Viz.ai will embed NeuroQuant and NeuroQuant MS into its care workflow platform
- Cortechs.ai's NeuroQuant products are FDA-cleared for quantitative neuroimaging and longitudinal tracking
- Initial deployment will focus on quantitative MRI analysis for multiple sclerosis